Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia.
Tahir SK, Calvo E, Carneiro BA, Yuda J, Shreenivas A, Jongen-Lavrencic M, Gort E, Ishizawa K, Morillo D, Biesdorf C, Smith M, Cheng D, Motwani M, Sharon D, Uziel T, Modi DA, Buchanan FG, Morgan-Lappe S, Medeiros BC, Phillips DC.
Tahir SK, et al.
Blood. 2023 Apr 27;141(17):2114-2126. doi: 10.1182/blood.2022017333.
Blood. 2023.
PMID: 36720090
Free PMC article.